Confluence Life Sciences

Launch date

2010

Employees

Market cap

Enterprise valuation

AUD155m (Public information from Aug 2017)

Saint-Louis Département de Saint-Louis (HQ)

Date	Investors	Amount	Round
-	Small Business Innovation Research (SBIR)	N/A	-
Apr 2011	Missouri Technology Corporation	$75.0k	Seed
Jul 2012	N/A	$900k	Seed
Sep 2012	BioGenerator Helix Fund Mercury Fund	$4.0m	Series A
Oct 2013	Mercury Fund	$500k	Series A
Feb 2014	Epidarex Capital	$1.0m	Series A
Jul 2015	BioGenerator Missouri Technology Corporation Epidarex Capital Mercury Fund St. Louis Arch Angels	$2.4m	Series B
Apr 2016	N/A	$4.8m	Early VC
Aug 2017	Aclaris Therapeutics	$100m Valuation: $100m	Acquisition
Total Funding		AUD21.1m

Tech stackLearn more about the technologies and tools that this company uses.

Recent News about Confluence Life Sciences